Analysis Tools
mortality/aging
|
• >50% of transgenics (lines 73 and 275) die by 40 weeks of age; line 70 mice do not show significant premature death
|
homeostasis/metabolism
|
• massive mural thrombi adjacent to damaged tissue in atria are observed
|
|
• upon necropsy, diseased mice show varying degrees of pleural effusions
|
cardiovascular system
|
• myocyte degeneration and vacuolization are observed in atria, consistent with myocarditis
|
|
• associated with myocarditis with lymphocytic infiltrates
|
|
• diseased mice upon death are found to have enlarged hearts with ischemic coloration
• most healthy-appearing mice display marked cardiac enlargement at 40 weeks
|
|
• ventricular inflammatory lesions are composed of large numbers of CD4+ and CD8+ T cells with many F4/80 macrophages and few B cells
|
|
• enlarged livers show changes characteristic of centrilobular hepatic necrosis and hemorrhage
|
|
• many transgenic mice display symptoms of congestive heart failure; line 70 transgenics do not develop symptoms of congestive heart failure
|
|
• hearts show extensive mononuclear infiltrates in the atria; ventricles show focal infiltrates
|
myocarditis
(
J:88055
)
|
• myocarditis development is transgene- and NOD-specific; the transgenics all exhibit myocarditis
|
endocrine/exocrine glands
|
• observed in transgenic and non-transgenic littermates with equal frequency
|
|
• transgenic mice show insulitis, but pancreatic beta cell damage is not sufficient to result in clinical diabetes
|
immune system
|
• hearts show extensive mononuclear infiltrates in the atria; ventricles show focal infiltrates
|
myocarditis
(
J:88055
)
|
• myocarditis development is transgene- and NOD-specific; the transgenics all exhibit myocarditis
|
|
• observed in transgenic and non-transgenic littermates with equal frequency
|
|
• transgenic mice show insulitis, but pancreatic beta cell damage is not sufficient to result in clinical diabetes
|
|
• transgenic mice line 73 show the highest prevalence and titers of cardiac tissue autoantibodies (16/18 mice are positive), while only 5/24 mice of line 70 are positive with lower antibody titers
|
liver/biliary system
|
• enlarged livers show changes characteristic of centrilobular hepatic necrosis and hemorrhage
|
|
• livers show pathological changes characteristic of severe cardiac insufficiency and centrilobular hepatic necrosis and hemorrhage
|
|
• upon necropsy, diseased mice show enlargement and darkening of the liver
|
digestive/alimentary system
|
• observed in transgenic and non-transgenic littermates with equal frequency
|
behavior/neurological
muscle
|
• myocyte degeneration and vacuolization are observed in atria, consistent with myocarditis
|
|
• associated with myocarditis with lymphocytic infiltrates
|
respiratory system
|
• upon necropsy, diseased mice show varying degrees of pleural effusions
|
|
• mice show acute onset of labored breathing
|
growth/size/body
|
• diseased mice upon death are found to have enlarged hearts with ischemic coloration
• most healthy-appearing mice display marked cardiac enlargement at 40 weeks
|
|
• upon necropsy, diseased mice show enlargement and darkening of the liver
|
cellular
|
• associated with myocarditis with lymphocytic infiltrates
|
